NCT04472299CompletedPhase 4
Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery: A Prospective Randomized Controlled Pilot Trial
Source: ClinicalTrials.gov · Last updated 5 Aug 2025
Brief summary (registry, in English)
The purpose if this pilot study is to determine if a perioperative infusion of 0.2% ropivacaine via bilateral T3 paravertebral catheters can decrease the incidence of new onset atrial fibrillation following primary CABG and/or valve surgery and compare a number of secondary outcomes.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 9 Jul 2020
- Start date
- 9 Apr 2021
- Primary completion date
- 8 Jul 2025
- Lead sponsor
- University of Minnesota
- Diseases
- Atrial fibrillation
- NCT number
- NCT04472299
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 32
- From 9 Apr 2021 to the primary completion date, 8 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
- Redo surgery
Other illness
- History of atrial fibrillation or flutter
- Contraindication to block placement including local anesthetic allergy, bleeding diathesis (physiologic or iatrogenic)
Lab values
- Left ventricular ejection fraction (LVEF) \< 30%
Other
- Infective endocarditis
- Body mass index \> 35kg/m2
- Pregnancy
Who the study is looking for
- \- Participants must be undergoing one of the following elective or urgent (but not emergent) surgeries: A) Primary Coronary Artery Bypass Graft (CABG) B) Primary Surgical Aortic Valve Replacement (sAVR) C) Primary Surgical Mitral Valve Replacement (sMVR) D) Combined CABG \& surgical valve replacement
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.